文献速递肺结节与肺癌

2022年全球肺癌组织学亚型发病率的地域差异与时间趋势:基于人群的研究

Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study.
PubMed 文献 · Lancet Respir Med · 2025-02-03

该研究基于GLOBOCAN 2022等数据,估计2022年全球男性肺癌新发1 572 045例,女性908 630例,并分析四种主要组织学亚型(腺癌、鳞癌、小细胞癌、大细胞癌)的年龄标准化发病率地域差异,以及1988-2017年19国的时间趋势和代际变化。

要点

  • 2022年全球男性114 486例、女性80 378例腺癌归因于环境PM污染。

核心结论

  • 全球四种主要肺癌亚型的发病率和时间趋势存在显著地域差异。
  • 研究强调需进一步识别导致肺癌风险模式变化的可能因果因素。

研究设计与样本

  • 基于人群的研究,使用GLOBOCAN 2022、五大洲癌症发病率第七至十二卷及非洲癌症登记网络成员数据。
  • 估计2022年四种主要组织学亚型(腺癌、鳞癌、小细胞癌、大细胞癌)按年份、性别和年龄组的国家发病率。
  • 采用joinpoint回归和年龄-时期-队列分析评估19个国家1988-2017年年龄标准化发病率的时间趋势。

临床怎么用

  • 临床医生应了解不同地区肺癌组织学亚型分布差异,辅助诊断与筛查策略的制定。
  • 关注环境PM污染对腺癌发病的归因负担,在风险评估和患者教育中考虑环境因素。
  • 结合性别和地区特异性发病率数据,优化肺癌早期发现和预防资源配置。

局限性

  • 研究为基于登记数据的估计性分析,部分地区的组织学亚型比例可能受数据代表性限制。
  • 归因于PM污染的腺癌病例数为模型估算,因果推断需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lung cancer is the most common cancer worldwide, yet the current epidemiological profile of lung-cancer incidence by histological subtype is only partly understood. We aimed to assess geographical variation in incidence of lung cancer by subtype worldwide in 2022, geographical variation in adenocarcinoma incidence attributable to ambient particulate matter (PM) pollution worldwide in 2022, temporal trends in lung-cancer incidence by subtype from 1988 to 2017 in 19 countries, and generational changes. METHODS: For this population-based study, we used data from the Global Cancer Observatory (GLOBOCAN) 2022, Cancer Incidence in Five Continents Volumes VII-XII, and members of the African Cancer Registry Network. To obtain national estimates of lung cancer in 2022 for the four main histological subtypes (ie, adenocarcinoma, squamous cell carcinoma [SCC], small-cell carcinoma, and large-cell carcinoma) by year, sex, and age group, we combined national estimates with representative, subsite-specific incidence proportions of lung cancer on the basis of recorded incidence data compiled in Cancer Incidence in Five Continents Volume XII and from members of the African Cancer Registry Network. We calculated country-specific, sex-specific, and age-specific proportions of and sex-specific and age-specific incidence rates per 100 000 people for all four histological subtypes. To account for differences in age composition between populations by country, we calculated age-standardised incidence rates (ASRs) per 100 000 people for lung cancer by subtype and sex at national and regional levels. We also quantified the burden of adenocarcinoma incidence attributable to ambient PM pollution for 179 countries in 2022. We conducted joinpoint regression and age-period-cohort analysis to assess temporal trends in ASRs in 19 countries by sex. FINDINGS: In 2022, we estimated that there were 1 572 045 new cases of lung cancer worldwide among male individuals, of which 717 211 (45·6%) were adenocarcinoma, 461 171 (29·4%) were SCC, 180 063 (11·5%) were small-cell carcinoma, and 101 861 (6·5%) were large-cell carcinoma. In 2022, we estimated that there were 908 630 new cases of lung cancer worldwide among female individuals, of which 541 971 (59·7%) were adenocarcinoma, 155 598 (17·1%) were SCC, 87 902 (9·7%) were small-cell carcinoma, and 59 271 (6·5%) were large-cell carcinoma. Among male individuals, the highest ASRs were in east Asia for adenocarcinoma (27·12 [95% CI 27·04-27·21] per 100 000 people), east Europe for SCC (21·70 [21·51-21·89] per 100 000 people) and small-cell carcinoma (9·85 [9·72-9·98] per 100 000 people), and north Africa for large-cell carcinoma (4·33 [4·20-4·45] per 100 000 people). Among female individuals, the highest ASRs were in east Asia for adenocarcinoma (19·04 [18·97-19·11] per 100 000 people), north America for SCC (5·28 [5·21-5·35] per 100 000 people) and small-cell carcinoma (4·28 [4·21-4·35] per 100 000 people), and north Europe for large-cell carcinoma (2·87 [2·78-2·96] per 100 000 people). We estimated that 114 486 adenocarcinoma cases among male individuals and 80 378 adenocarcinoma cases among female individuals were attributable to ambient PM pollution worldwide in 2022, with ASRs of 2·35 (95% CI 2·33-2·36) per 100 000 male individuals and 1·46 (1·45-1·47) per 100 000 female individuals. Temporal trends in lung-cancer incidence by subtype and sex during 1988-2017 varied considerably across the 19 countries. INTERPRETATION: Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our study highlights the need for future studies that identify possible causal factors that contribute to the changing risk patterns of lung cancer. FUNDING: Natural Science Foundation of China Young Scientist Fund, Medical Scientific Research Foundation of Guangdong Province in China, and Young Innovative Talents Project of General Universities in Guangdong Province in China.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Luo G, Zhang Y, Rumgay H, et al. Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study. Lancet Respir Med. 2025. PMID: 39914442. doi:10.1016/S2213-2600(24)00428-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。